- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01786577
Study To Analyze Memory/Thinking Problems In Older Adults After Surgery (POCD)
Neuroimaging Biomarkers for Post-Operative Cognitive Decline in Older Adults
Study Overview
Status
Intervention / Treatment
Detailed Description
Cognitive impairment after major cardiac or non-cardiac surgery occurs in a high rate for older adults. The results of previous studies indicate that certain neuro-imaging markers can determine which individuals pose a greater risk for memory and thinking changes after surgery. Based on a pilot study, there is evidence that pre-surgical neuroimaging biomarkers associate with memory and executive decline after a well controlled surgical procedure (total knee antroplasty). In this study, researchers will use brain imaging studies to determine which patients are most likely to be affected by cognitive changes after this type of surgery. The use of Magnetic Resonance Imaging (MRI) will help investigators identify brain biomarkers that are associated with cognitive problems, such as white matter abnormalities and changes to small blood vessels. Patients undergoing total knee replacement surgery, as well as a group of non-surgery participants of similar age, education and health status,will receive cognitive testing and MRI brain scans before and after surgery/non-surgery. Researchers will compare and monitor both groups up to one year after surgery/non-surgery.
Prior to enrollment, participants will be asked to review the informed consent and provide written consent to participate in the study. The enrollment phase will involve in-person baseline assessment of cognitive functioning within two weeks of the scheduled surgery/non-surgery in order to rule out exclusion criteria. Testing will be in cooperation with the University of Florida General Clinical Research Center. Post-baseline MRI will be conducted on all participants (surgery/control) within 48 hours of the surgery/pseudo-surgery date to identify acute stroke differences from baseline. Cognitive assessments will be conducted for each participant at three-weeks, three-months, and one-year after surgery.
The research is highly significant because it will be the first study to use in-vivo diffusion imaging methods to examine the contribution of specific presurgical neuroanatomical vulnerabilities on executive and memory cognitive decline after one of the most common orthopedic surgeries sought by older adults. Additionally, it will be the first study to examine how specific neuroimaging biomarkers interact negatively with specific peri-operative variables including emboli number during surgery, embolic changes to the brain, anesthesia depth, and cerebral oxygenation.
The findings of the study will improve pre-surgery screening procedures for older adults and assist with the development of peri-operative interventions that will prevent neurodegenerative disease acceleration.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- University of Florida
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Planned total unilateral knee antroplasty or non-surgical knee osteoarthritis
- Age 60 years or older at the time of baseline assessment
- Telephone screening and in-person baseline cognitive testing not supportive of dementia
- Handedness: Right handed; restriction to left-right hemisphere laterality and white matter pathways
- Participant and family deny presence of difficulties with Instrumental Activities of Daily Living (IADL)
- All ethnic and racial groups will be recruited
Exclusion Criteria:
Underlying medical diseases likely to limit lifespan or confound outcome analyses:
- cancer requiring treatment in past five years
- serious infectious diseases
- congestive heart failure
- chronic hepatitis
- history of organ transplantation
- seizure disorders
- history of head trauma resulting in intensive care
- current diagnosis of alcoholism, drug dependence, history of major tranquilizer use
Neurodegenerative Exclusions:
- history of major stroke
- exposure to toxins or neuroleptics
- history of encephalitis
- neurological signs of upper motor neuron disease, cerebellar involvement, supranuclear palsy, or significant orthostatic hypertension
- signs of dementia.
Psychiatric Exclusions:
- major psychiatric disorder
- major depression
Conditions or behaviors likely to affect imaging or cognitive testing:
- claustrophobia
- non-medical bodily metal, pace-maker device
- less than five years of formal education
- inability to read or write
- self-reported hearing difficulty that interferes with standardized test administration
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Surgery
80 patients will undergo total knee replacement surgery; two Magnetic Resonance Imaging scans; cognitive assessment testing.
|
Both groups will undergo two MRIs at baseline and within 48 hours after surgery/non-surgery.
Other Names:
Both groups will undergo in-person baseline assessment of cognitive functioning as well as assessments at three weeks, three months and one year.
Other Names:
|
Non-Surgery
80 non-surgery participants will be included as part of the control group; two Magnetic Resonance Imaging scans; cognitive assessment testing.
|
Both groups will undergo two MRIs at baseline and within 48 hours after surgery/non-surgery.
Other Names:
Both groups will undergo in-person baseline assessment of cognitive functioning as well as assessments at three weeks, three months and one year.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Predicting Executive Decline
Time Frame: baseline, 3 weeks, 3 months, 1 year
|
Severity of pre-surgical/baseline neuroimaging markers of cerebrovascular disease will predict post-operative executive decline at 3 weeks, 3 months and 1 year.
|
baseline, 3 weeks, 3 months, 1 year
|
Predicting Memory Decline
Time Frame: baseline, 3 weeks, 3 months, 1 year
|
Pre-surgical/baseline neuroimaging markers of entorhinal-hippocampal white matter connectivity will predict post-operative memory decline at 3 weeks, 3 months and 1 year.
|
baseline, 3 weeks, 3 months, 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Catherine Price, Ph.D, University of Florida
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB201601040-N
- R01NR014181-01 (U.S. NIH Grant/Contract)
- 487-2012 (Other Identifier: UF legacy)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-Operative Cognitive Decline in Older Adults
-
University of Lausanne HospitalsUniversité Catholique de Louvain; Mindmaze SA; Centre de Recherche de l'Institut... and other collaboratorsCompletedCognitive Decline Prevention in Robust Older Adults | Cognitive Decline Prevention in Pre-frail Older Adults | Physical Decline Prevention in Robust Older Adults | Physical Decline Prevention in Pre-frail Older AdultsBelgium, Canada, Switzerland
-
Jewish General HospitalActive, not recruitingDepression | Older Adults | Cognitive DeclineCanada
-
Albert Einstein College of MedicineNational Institute on Aging (NIA)CompletedPost-operative Delirium | Post-operative Cognitive DeclineUnited States
-
Universidad de GranadaCompletedHealthy Aging | Older Adults | Cognitive Decline | Functional AbilitySpain
-
University of FloridaNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedCognitive Function | Older Adults | Physical FunctionUnited States
-
University of Alabama at BirminghamCompletedPhysical Fitness in Older AdultsUnited States
-
University of ZurichCompletedMotivation in Healthy Older AdultsSwitzerland
-
Weill Medical College of Cornell UniversityNational Institute on Aging (NIA)Completed
-
Northwestern UniversityRecruitingImproving Cardiometabolic Outcomes in Older AdultsUnited States
-
University of ExtremaduraRecruiting
Clinical Trials on Magnetic Resonance Imaging
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterActive, not recruitingProstate Adenocarcinoma | Prostate CarcinomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityRecruitingIntracranial NeoplasmUnited States
-
University of California, San FranciscoTerminatedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Healthy SubjectUnited States
-
Stanford UniversityTerminatedLaryngeal Neoplasms | Head and Neck Cancers | Larynx CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedBrain TumorUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedThoracic Spine NeoplasmUnited States